One permanent genome. A health record designed to grow.
The core is deliberately clear: full DNA for dogs and cats and a report that can be re-read. Additional layers enter only as their evidence and operating model are ready.
Aevum Pet
- Target 30× whole-genome sequencing
A home cheek swab or saliva sample is processed by a sequencing laboratory to create a full genomic baseline for a dog or cat.
- Raw-data archive
The underlying data is retained for portability and future reinterpretation, rather than reduced to a one-time breed or trait result.
- Initial interpretation report
Findings are prioritised, evidence-graded and written with explicit limits.
- Genome reinterpretation
Relevant new species-specific evidence can update the reading without resequencing the pet.
- Longitudinal digital record
New measurements and veterinary context can be brought into one traceable timeline.
No fixed price or launch configuration is being claimed while supplier, assay and regional decisions remain open.
Promising does not mean ready
The blueprint includes recurring measurements, but each is labelled by its actual stage.
Epigenetic / methylation age
Requires a species-specific assay with demonstrated validity and repeatability.
Veterinary blood biomarkers
Depends on standardised panels and country-specific veterinary workflows.
Continuous physiology
Integrate existing collar-device data before considering proprietary hardware.